http://www.marketwatch.com/story/tearlab-shares-soar-on-medicare-update-2010-10-08
By Val Brickates Kennedy
BOSTON (MarketWatch) — Shares of diagnostic test developer TearLab Corp. (TEAR 3.08, +0.35, +12.82%) soared in early action Friday after it announced that its TearLab Osmolarity test is now eligible for reimbursement by the Medicare and Medicaid health care programs. The test is used to help diagnose “dry eye” disease. TearLab shares were up 12% at $3.05
